植物医生IPO闯关，解码国妆硬核出海新姿势

Core Insights - The domestic high-altitude plant skincare brand DR PLANT is updating its IPO process and plans to list on the Shenzhen Stock Exchange main board, supported by over 4,200 offline stores and a focus on "high-altitude plants" to differentiate itself in a homogenized market [1] R&D and Innovation - The company's prospectus emphasizes its R&D structure and technological achievements, indicating that its core competitive advantage lies in systematic research capabilities [3] - A unique asset is the deep collaboration with the Kunming Institute of Botany, Chinese Academy of Sciences, leading to the establishment of the Zhongke Kunzh plant doctor R&D center, which serves as the "brain" for product innovation [3] - The company has established five R&D bases across Beijing, Guangdong, Yunnan, Jiangsu, and Tokyo, creating a global R&D network covering fundamental research, raw material development, formulation processes, clinical testing, and Eastern skincare science [3] - As of October 2025, the company has obtained 223 patents, including 68 invention patents, establishing a solid intellectual property moat [3] - A notable achievement is the deep development of "Dendrobium," where patented technology converts large molecular Dendrobium polysaccharides into more absorbable Dendrobium oligosaccharides, proving effective in promoting collagen regeneration in the skin [3] Market Strategy and Channel Development - The company has chosen a "heavier" but more stable channel strategy, with 4,269 global single-brand chain stores and over 30 million members as of June 2025, recognized for two consecutive years by Euromonitor as a "global leader in single-brand skincare specialty stores" [4] - Stores serve not only as sales terminals but also as brand experience centers offering professional care and member salons, creating unique emotional value and user stickiness, transforming one-time purchases into long-term membership relationships [4] - The extensive offline network provides a predictable revenue base, mitigating risks from online traffic fluctuations, while millions of members form a rich private traffic pool for product iteration and precise marketing [4] - The capital journey coincides with a critical shift in the domestic cosmetics industry from internal competition to external value expansion, with a successful IPO expected to open a new development phase for the company [4] - The challenge lies in leveraging capital advantages to accelerate expansion while maintaining brand tone and operational quality, with the balance between scale and efficiency being crucial for establishing a strong global presence [4]